This position is no longer accepting applications
Vice President, Head of R&D at Revvity has been filled or removed.
We'll email you when new roles in France; Turku; Germany -Revvity are posted.
About Us
Revvity is a developer and provider of end-to-end solutions designed to help scientists, researchers, and clinicians solve the world’s greatest health challenges. We pair the enthusiasm of an industry disruptor with the experience of a longtime leader. Our team of 11,000+ colleagues from around the globe are vital to our success and the reason we’re able to push boundaries in pursuit of better human health.
Find your future at Revvity
Revvity is seeking a highly experienced Vice President, Head of R&D to lead the execution of our global R&D roadmap across the full product and technology portfolio. This is a newly created, high-impact leadership role designed to bring strategic coherence, operational rigor, and cross-functional alignment to our R&D organization. This leader will also play a critical role in advancing Revvity’s next generation of AI-enabled products, and data-driven solutions across the portfolio.
Reporting to our Chief Business Officer, this individual will be responsible for assessing the current R&D organization, defining an optimal structure around core capabilities, and driving execution in close partnership with our portfolio managers.
Key Responsibilities
Organizational Design & Capability Building
R&D Strategy & Roadmap Execution
Global Operations & Governance
Cross-Functional Leadership
Qualifications
Required
Preferred
DIAGNOSTICS
This listing was originally posted on Revvity's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access salary benchmarks and market rate data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo